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In the previous issue of Critical Care Dunser and 
colleagues presented the results of post-hoc analysis that 
add another piece to the puzzle of understanding optimal 
arterial pressure goals in the treatment of sepsis [1]. Th  e 
authors examine data from a control group of severe 
sepsis patients enrolled in an interventional trial that 
mandated hemo  dynamic management to speciﬁ  c thera-
peutic targets, one of which was achievement of a mean 
arterial pressure (MAP) of 70 mmHg or higher through 
the use of vaso  pressors. Dunser and colleagues analyzed 
the association between the average MAP, both as a 
continuous variable and grouped into quartiles, and 
mortality. What they found was no association between 
average MAP, or MAP quartiles above 70 mmHg, and 
28-day mortality. Th  ey did, however, report an associa-
tion between vasopressor load and mortality.
In his classic text Physiology of Shock published in 1950, 
Dr Carl J Wiggers wrote ‘In short, there are no patho-
gnomonic signs of shock … Th   e instability of a patient’s 
condition, along with progressive deterioration, 
constitutes the best evidence of shock. In the assessment 
of such determination, the trend of arterial pressures 
remains one of our best criteria’ [2]. For over a century, 
arterial hypotension has been intensely studied as a central 
cause of organ hypoperfusion and subsequent organ injury 
in critically ill patients. Th  is includes patients with 
hemor  rhage [2], heterogeneous populations of pre-
hospital patients [3] and emergency department patients 
[4], and speciﬁ   c disease states such as pulmonary 
embolism [5], acute myocardial infarction [6], post-
cardiac arrest syndrome [7], and sepsis [8]. Because of 
both the universal availability of its measurement and its 
association with severity of illness, medical care providers 
frequently use blood pressure to communicate with each 
other about the hemodynamic stability of patients.
We agree with the authors’ contention that consensus 
recommendation of a goal for MAP as a therapeutic 
target in septic shock management is more or less an 
arbitrary number that represents a minimal threshold 
that experts would consider clinically acceptable [9]. One 
randomized controlled trial for the resuscitation of 
patients with sepsis used a MAP of 65 mmHg or higher 
as a goal for hemodynamic support; however, the MAP 
goal was part of the interventional algorithm for both 
arms of the trial (that is, treatment and control) and 
therefore MAP was eﬀ   ectively removed from the 
experiment [10]. Th  e data presented in Dunser and 
colleagues’ study are important and allow the conclusion 
that, during routine management of patients with severe 
sepsis, there is no association between MAP achieved 
and outcome as long as the MAP is maintained at or 
above 70 mmHg.
It is important to note in this study, however, that a 
MAP of 70 mmHg was not tested as a threshold or target 
for hemodynamic support. Th   is would have required an 
investigation in which patients were assigned to diﬀ  erent 
MAP thresholds as therapeutic targets (for example, 
60 mmHg, 65 mmHg, 70 mmHg, and so forth) and out-
comes were compared between these groups. No such 
large-scale deﬁ  nitive study has been performed to date. 
Abstract
Arterial pressure optimization in septic shock is 
a critical, yet poorly understood component of 
resuscitation. New data suggest that, during the 
routine management of patients with severe sepsis, 
there is no association between mean arterial 
pressure achieved and outcome as long as the mean 
arterial pressure is maintained at or above 70 mmHg. 
Although these data add important new evidence to 
our understanding of arterial pressure management, 
there are still many unanswered questions upon which 
future investigations should focus.
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recommendations and our best clinical judgment.
Another important point of discussion of Dunser and 
colleagues’ report centers on a secondary ﬁ  nding. Th  ey 
conclude that their data indicate an association between 
vasopressor load and both mortality and disease-related 
events. Intuitively this makes sense: the more vasopressor 
support a patient requires, the more severely ill the 
patient is and thus the more likely the patient is to suﬀ  er 
either drug or disease-related morbidity and mortality. 
Th   ese data do not, however, allow the conclusion stated 
in their paper – that elevating MAP >70 mmHg by 
augmenting vasopressor dosages may increase mortality. 
Th  is conclusion would require an experimental design 
that allowed testing of cause and eﬀ  ect rather than an 
analysis of association. In our opinion, a more likely 
reason for the association between higher vasopressor 
doses and poor outcome would be some combination of 
more refractory sepsis-induced vasodilation and lower 
cardiac output, both assumed to be linked to poorer 
prognosis. An important consideration as it relates to 
vasopressor therapy is being constantly vigilant in 
minimizing vasopressor dosage by targeting the lowest 
pressure that can be assured to be providing adequate 
tissue perfusion while assuring that additional volume 
infusion – or, in some patients, inotropic therapy – will 
allow reduction of vasopressor therapy.
Th  ere are many factors about the cardiovascular 
support of sepsis that remain relatively unknown. Although 
arterial blood pressure is important and is clearly asso-
ciated with outcome, the overarching goal of cardio-
vascular support is to optimize blood ﬂ  ow to tissues. Th  e 
relationship between arterial pressure and ﬂ  ow  is 
complex and incompletely understood [11]. Th  ere is 
possibly also no single optimal MAP that can be applied 
to all sepsis patients, as patient-speciﬁ   c factors are 
probably extremely important in determining patient 
response. Pre-existing disease, intact autoregulation and 
distribution of ﬂ  ow, among other factors, all play a role in 
the optimal MAP level an individual patient needs in 
order to achieve optimal outcomes.
Let us suppose for a moment that an optimal MAP for 
sepsis cardiovascular support was clearly identiﬁ  ed, 
associated with improved outcomes, and widely accepted 
and utilized in clinical care. While a critical piece of the 
sepsis puzzle would be ﬁ  lled, many others would still be 
missing – such as the optimal time frame in which the 
goal should be reached, the optimal therapeutic methods 
to achieve the goal (for example, ﬂ  uids, vasopressors), 
and how long the goal must be maintained. So it appears 
that the more we learn about cardiovascular support in 
sepsis, the less we actually know.
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